Week in review: COVID again, FDA approvals, VEGF alternative

This week, clinicians report another possible ocular manifestation of COVID-19, the FDA approves new drugs for dry eye and pediatric vernal keratoconjuncitivitis, and researchers propose a new mechanism to treat retinal diseases.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553